Case-control studies in the genomic era: a clinician's guide

Lancet Neurology

Volumn 5, Issue 8, 2006, Pages 701-707

  Healy, Daniel G ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

CASE CONTROL STUDY; DNA SEQUENCE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME ANALYSIS; HAPLOTYPE; HERITABILITY; HUMAN; HUMAN GENOME; LINKAGE ANALYSIS; NATURAL SELECTION; PHENOTYPIC VARIATION; POPULATION GENETICS; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; TANDEM REPEAT;

CASE-CONTROL STUDIES; CHROMOSOME MAPPING; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GENOME, HUMAN; HUMANS; LINKAGE DISEQUILIBRIUM; PHENOTYPE; PUBLICATION BIAS; VARIATION (GENETICS);

EID: 33746124235     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(06)70524-5     Document Type: Review

References (95)

1. Cavalleri G., Lynch J., Depondt C., et al. Failure to replicate previously reported genetic associations with sporadic temporal lobe epilepsy: where to from here?. Brain 128 (2005) 1832-1840
2. Klein R., Zeiss C., Chew E., et al. Complement factor H polymorphism in age-related macular degeneration. Science 308 (2005) 385-389
3. Haines J., Hauser M., Schmidt S., et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 308 (2005) 419-421
4. Edwards A., Ritter III R., Abel K., Manning A., Panhuysen C., and Farrer L. Complement factor H polymorphism and age-related macular degeneration. Science 308 (2005) 421-424
5. Breslow N., and Day N. Statistical methods in cancer research, volume 1: the analysis of case-control studies. IARC Sci Publ 32 (1980) 5-328
6. Kruglyak L., and Nickerson D. Variation is the spice of life. Nat Genet 27 (2001) 234-236
7. Cavalli-Sforza L., Menozzi P., and Piazza A. The history and geography of human genes (1994), Princeton University Press, Princeton
8. Pritchard J., and Cox N. The allelic architecture of human disease genes: common disease-common variant...or not?. Hum Mol Genet 11 (2002) 2417-2423
9. Ueda H., Howson J., Esposito L., et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423 (2003) 506-511
10. Todd J. Human genetics. Tackling common disease. Nature 411 (2001) 537
11. Cohen J., Kiss R., Pertsemlidis A., Marcel Y., McPherson R., and Hobbs H. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305 (2004) 869-872
12. Blangero J. Localisation and identification of human quantitative trait loci: King harvest has surely come. Curr Opin Genet Dev 14 (2004) 233-240
13. Barton N., and Keightley P. Understanding quantitative genetic variation. Nat Rev Genet 3 (2002) 11-21
14. Hoogendoorn B., Coleman S., Guy C., et al. Functional analysis of human promoter polymorphisms. Hum Mol Genet 12 (2003) 2249-2254
15. Lo H., Wang Z., Hu Y., et al. Allelic variation in gene expression is common in the human genome. Genome Res 13 (2003) 1855-1862
16. Schuler G., Boguski M., Steward E., et al. A gene map of the human genome. Science 274 (1996) 540-546
17. Lander E., Linton L., Birren B., et al. Initial sequencing and analysis of the human genome. Nature 409 (2001) 860-921
18. Venter J., Adams M., Myers E., et al. The sequence of the human genome. Science 291 (2001) 1304-1351
19. Couzin J. Human genome: HapMap launched with pledges of $100 million. Science 298 (2001) 941-942
20. Altshuler D., Brooks L., Chakravarti A., Collins F., Daly M., and Donnelly P. International HapMap Consortium: a haplotype map of the human genome. Nature 437 (2005) 1299-1320
21. The International HapMap Consortium. A haplotype map of the human genome. Nature 437 (2005) 1299-1320
22. Hirose S., Mitsudome A., Okada M., and Kaneko S. Genetics of idiopathic epilepsies. Epilepsia 46 suppl 1 (2005) 38-43
23. Schmidt D., and Rogawski M. New strategies for the identification of drugs to prevent the development or progression of epilepsy. Epilepsy Res 50 (2002) 71-78
24. Neale B., and Sham P. The future of association studies: gene-based analysis and replication. Am J Hum Genet 75 (2004) 353-362
25. Biskup S., Mueller J., Sharma M., et al. Common variants of LRRK2 are not associated with sporadic Parkinson's disease. Ann Neurol 58 (2005) 905-908
26. Skipper L., Li Y., Bonnard C., et al. Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson's disease. Hum Mol Genet 14 (2005) 3549-3556
27. Strittmatter W., Saunders A., Schmechel D., et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90 (1993) 1977-1981
28. Craig D., and Stephan D. Applications of whole-genome high-density SNP genotyping. Expert Rev Mol Diagn 5 (2005) 159-170
29. Syvanen A. Toward genome-wide SNP genotyping. Nat Genet 37 suppl (2005) S5-S10
30. Goldstein D. Islands of linkage disequilibrium. Nat Genet 29 (2001) 109-111
31. Gabriel S., Schaffner S., Nguyen H., et al. The structure of haplotype blocks in the human genome. Science 296 (2002) 2225-2229
32. Johnson G., Esposito L., Barratt B., et al. Haplotype tagging for the identification of common disease genes. Nat Genet 29 (2003) 233-237
33. Weale M., Depondt C., Macdonald S., et al. Selection and evaluation of tagging SNPs in the neuronal-sodium-channel gene SCN1A: implications for linkage-disequilibrium gene mapping. Am J Hum Genet 73 (2003) 551-565
34. Peltonen L., and McKusick V. Genomics and medicine: dissecting human disease in the postgenomic era. Science 291 (2001) 1224-1229
35. Goldstein D., Ahmadi K., Weale M., and Wood N. Genome scans and candidate gene approaches in the study of common diseases and variable drug responses. Trends Genet 19 (2003) 615-712
36. Ahmadi K., Weale M., Xue Z., et al. A single-nucleotide polymorphism tagging set for human drug metabolism and transport. Nat Genet 37 (2005) 84-89
37. Halldorsson B., Istrail S., and De La Vega F. Optimal selection of SNP markers for disease association studies. Hum Hered 58 (2004) 190-202
38. Botstein D., and Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet 33 suppl (2003) 228-237
39. Carlson C., Eberle M., Kruglyak L., and Nickerson D. Mapping complex disease loci in whole-genome association studies. Nature 429 (2004) 446-452
40. Hirschhorn J., Lohmueller K., Byrne E., and Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 4 (2002) 45-61
41. Lohmueller K., Pearce C., Pike M., Lander E., and Hirschhorn J. Meta-analysis of genetic association studies supports a contribution of common variants to common disease. Nat Genet 33 (2003) 177-182
42. Ioannidis J., Ntzani E., Trikalinos T., and Contopoulos-Ioannidis D. Replication validity of genetic association studies. Nat Genet 29 (2001) 306-309
43. Freimer N., and Sabatti C. The human phenome project. Nat Genet 34 (2003) 15-21
44. Gibb W., and Lees A. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51 (1988) 745-754
45. McDonald W., Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50 (2001) 121-127
46. Sander H., and Latov N. Research criteria for defining patients with CIDP. Neurology 60 suppl 3 (2003) S8-S15
47. Flossmann E., Schulz U., and Rothwell P. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke 35 (2004) 212-227
48. Hughes A., Daniel S., Kilford L., and Lees A. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55 (1992) 181-184
49. Bromberg J., Rinkel G., Algra A., et al. Subarachnoid haemorrhage in first and second-degree relatives of patients with subarachnoid haemorrhage. BMJ 311 (1995) 288-289
50. Kubota M., Yamaura A., Ono J., et al. Is family history an independent risk factor for stroke?. J Neurol Neurosurg Psychiatry 62 (1997) 66-70
51. Dichgans M., and Markus H. Genetic association studies in stroke: methodological issues and proposed standard criteria. Stroke 36 (2005) 2027-2031
52. Kurz A., Riemenschneider M., and Wallin A. Potential biological markers for cerebrovascular disease. Int Psychogeriatr 15 suppl 1 (2003) 89-97
53. Masuda J., Nabika T., and Notsu Y. Silent stroke: pathogenesis, genetic factors and clinical implications as a risk factor. Curr Opin Neurol 14 (2001) 77-82
54. Rothman K., and Greenland S. Modern Epidemiology (1998), Lippincott-Raven, Philadelphia
55. Wright A., Carothers A., and Campbell H. Gene-environment interactions: the BioBank UK study. Pharm J 2 (2002) 75-82
56. Purcell S., Cherny S., and Sham P. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19 (2003) 149-150
57. Goldstein D., Tate S., and Sisodiya S. Pharmacogenetics goes genomic. Nat Rev Genet 4 (2003) 937-947
58. Healy D., Abou-Sleiman P., Quinn N., and European MSA Study Group. UCHL-1 gene in multiple system atrophy: a haplotype tagging approach. Mov Disord 20 (2005) 1338-1343
59. Vanacore N. Epidemiological evidence on multiple system atrophy. J Neural Transm 112 (2005) 1605-1612
60. Risch N., and Merikangas K. The future of genetic studies of complex human disease. Science 273 (1996) 1516-1517
61. Ott J. Association of genetic loci. Neurology 63 (2004) 955-958
62. Dahlman I., Eaves I., Kosoy R., et al. Parameters for reliable results in genetic association studies in common disease. Nat Genet 3 (2002) 149-150
63. Colhoun H., McKeigue P., and Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 361 (2003) 865-872
64. Armitage P., and Berry G. Statistical methods in medical research. 3rd edn. (1994), Blackwell Scientific Publications, Cambridge, MA
65. Hsu J. Multiple comparisons: theory and methods (1996), Chapman & Hall, New York
66. Knowler W., Williams R., Pettitt D., and Steinberg A. Gm 3; 5, 13, 14 and Type 2 diabetes mellitus: an association in American Indians with genetic admixture. Am J Hum Genet 43 (1988) 520-526
67. Blum K., Noble E., Sheridan P., et al. Allelic association of human dopamine D(2) receptor gene in alcoholism. JAMA 263 (1990) 2055-2060
68. Gelernter J., Goldman D., and Risch N. The A1 allele at the DZ dopamine receptor gene and alcoholism: a reappraisal. JAMA 269 (1993) 1673-1677
69. Cardon L., and Palmer L. Population stratification and spurious allelic association. Lancet 361 (2003) 598-604
70. Ardlie K., Lunetta K., and Seielstad M. Testing for population subdivision and association in four case control studies. Am J Hum Genet 71 (2002) 304-311
71. Wacholder S., Rothman N., and Caporaso N. Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J Natl Cancer Inst 92 (2000) 1151-1218
72. Helgason A., Yngvadottir B., Hrafnkelsson B., Gulcher J., and Stefansson K. An Icelandic example of the impact of population structure on association studies. Nat Genet 37 (2005) 90-95
73. Eaves L., and Sullivan P. Genotype-environment interaction in transmission disequilibrium tests. Adv Genet 42 (2001) 223-240
74. Devlin B., and Roeder K. Genomic control for association studies. Biometrics 55 (1999) 997-1004
75. Pritchard J., and Rosenberg N. Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet 65 (1999) 220-228
76. Hoggart C., Esteban J., Shriver M., et al. Control of confounding of genetic association in stratified populations. Am J Hum Genet 72 (2003) 1492-1504
77. Reich D., and Goldstein D. Detecting association in a case-control study while correcting for population stratification. Genet Epidemiol 20 (2001) 4-16
78. Rosenthal R. The "File Drawer Problem" and tolerance for null results. Psychol Bull 86 (1979) 6638-6641
79. Kennedy D. The old file-drawer problem. Science 305 (2004) 451
80. Light R., and Pillemar D. Summing up: the science of research (1984), Harvard University Press, Cambridge, MA
81. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7 (1986) 177-188
82. Soranzo N., Cavalleri G., Weale M., et al. Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene. Genome Res 14 (2004) 1333-1344
83. Goldstein D. Pharmacogenetics in the laboratory and the clinic. N Engl J Med 348 (2003) 553-556
84. Cliften P., Sudarsanam P., Desikan A., et al. Finding functional features in Saccharomyces genomes by phylogenetic footprinting. Science 301 (2003) 71-76
85. Boguski M., and Jones A. Neurogenomics: at the intersection of neurobiology and genome sciences. Nat Neurosci 7 (2004) 429-433
86. ENCODE Project Consortium. The ENCODE (ENCyclopedia Of DNA Elements) Project. Science 306 (2004) 636-640
87. Bassett Jr. D., Boguski M., Spencer F., Reeves R., Goebl M., and Hieter P. Comparative genomics genome cross-referencing and XREFdb. Trends Genet 11 (1995) 372-373
88. Chimpanzee Sequencing and Analysis Consortium. Initial sequence of the chimpanzee genome and comparison with the human genome. Nature 437 (2005) 69-87
89. Gatewood B., and Cottingham R. Mouse-human comparative map resources on the Web. Brief Bioinform 1 (2000) 60-75
90. Marcus G. The birth of the mind: how a tiny number of genes create the complexities of human thought (2004), Basic books, New York
91. Tietjen I., Rihel J., Cao Y., Koentges G., Zakhary L., and Dulac C. Single-cell transcriptional analysis of neurone progenitors. Neuron 38 (2003) 161-171
92. Collins F. BRCA1-lots of mutations, lots of dilemmas. N Engl J Med 334 (1996) 186-188
93. The American Society of Clinical Oncology. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility. J Clin Oncol 14 (1996) 1730-1736
94. Paulson H. Diagnostic testing in neurogenetics. Principles, limitations, and ethical considerations. Neurol Clin 20 (2002) 627-643
95. Hofman K., Tambor E., Chase G., Geller G., Faden R., and Holtzman N. Physicians' knowledge of genetics and genetic tests. Acad Med 68 (1993) 625-631